BRIEF published on 03/11/2026 at 09:05, 3 months 15 days ago Aiforia Technologies Oyj Sees Clinical Growth Surge European Market Cash Position Profitability Improvement Client Expansion Clinical Growth
PRESS RELEASE published on 03/11/2026 at 09:00, 3 months 15 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj by NuWays AG analyzed: Clinical growth accelerates, profitability improves with increased share of wallet and workforce reductions. Target price EUR 3.8 Profitability NuWays AG Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 03/09/2026 at 09:05, 3 months 17 days ago Aiforia Technologies Oyj prête pour la croissance dans le segment clinique Partenariats Stratégiques Part De Marché Amélioration De L'EBITDA Expansion Des Revenus Croissance Clinique
BRIEF published on 03/09/2026 at 09:05, 3 months 17 days ago Aiforia Technologies Oyj Poised for Growth in Clinical Segment Strategic Partnerships Revenue Expansion EBITDA Improvement Market Share Clinical Growth
PRESS RELEASE published on 03/09/2026 at 09:00, 3 months 17 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj's clinical segment shows strong growth with a clear roadmap for scaling, leading to improved profitability and strategic partnerships. Research recommends buying with a target price of EUR 3.80 Strategic Partnerships Profitability Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 02/27/2026 at 09:05, 3 months 27 days ago Aiforia Technologies Oyj anticipe une forte croissance de ses revenus cliniques Croissance Financière Rentabilité Partenariats Stratégiques Technologie IA Revenus Cliniques
BRIEF published on 02/27/2026 at 09:05, 3 months 27 days ago Aiforia Technologies Oyj Anticipates Strong Clinical Revenue Growth Strategic Partnerships AI Technology Profitability Financial Growth Clinical Revenue
PRESS RELEASE published on 02/27/2026 at 09:00, 3 months 27 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj's updated research report by NuWays AG reveals accelerated clinical revenue growth expectations, with key focus on AI technology adoption and strategic partnerships for sales growth NuWays AG Research Report Aiforia Technologies Oyj Clinical Revenue Growth AI Technology Adoption
BRIEF published on 02/11/2026 at 09:05, 4 months 15 days ago La voie innovante vers la rentabilité d'Aiforia Technologies Oyj Rentabilité Imagerie Médicale Technologies Aiforia Transformateur De Vision Moteur De Fondation
BRIEF published on 02/11/2026 at 09:05, 4 months 15 days ago Aiforia Technologies Oyj's Innovative Path to Profitability Profitability Medical Imaging Aiforia Technologies Vision Transformer Foundation Engine
Published on 06/27/2026 at 01:40, 6 hours 54 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 8 hours 34 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 9 hours 34 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 9 hours 44 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 10 hours 19 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 8 hours 29 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 8 hours 30 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 8 hours 58 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 8 hours 58 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 9 hours 6 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 17:45, 14 hours 49 minutes ago Descriptif du programme de rachat d'actions
